LB PHARMACEUTICALS INC
Public company- Headquarters
- NEW YORK, New York
- Ticker
- LBRX
- CIK
- 0001691082
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
2
2 appointments, 0 departures
Last event
Sep 15, 2026
Executive appointmentCMO appointed: Susan G. Kozauer, M.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CMOSusan G. Kozauer, M.D. | Sep 15, 2026 | Appointed |
| CFOJoseph M. Miller | Sep 3, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- PFIZER INC
CFO appointed: Cecile Guegan
- ROCKET PHARMACEUTICALS, INC.
WARN notice: Cranbury, NJ
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Executive appointment
CMO appointed: Susan G. Kozauer, M.D.
Susan G. Kozauer, M.D. was named Chief Medical Officer of LB PHARMACEUTICALS INC, effective September 14, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 15, 2026Role: Chief Medical Officer
- Executive appointment
CFO appointed: Joseph M. Miller
Joseph M. Miller was named Chief Financial Officer of LB PHARMACEUTICALS INC, effective September 2, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 3, 2026Role: Chief Financial Officer
Last verified Nov 8, 2026